Skip to main content
Inventage Lab Inc. logo

Inventage Lab Inc. — Investor Relations & Filings

Ticker · 389470 ISIN · KR7389470006 KO Professional, scientific and technical activities
Open in API
Filings indexed 195 across all filing types
Latest filing 2026-02-04 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 389470

About Inventage Lab Inc.

https://www.inventagelab.com/m/en/

Inventage Lab Inc. is a biopharmaceutical company specializing in the development of advanced Drug Delivery Systems (DDS). The company's foundation is its proprietary microfluidics-based platform technology, Laminar-FluiDigm™, which is applied to pharmaceutical research and manufacturing. Inventage Lab operates two primary platforms: IVL-DrugFluidic® for developing and producing microsphere-based long-acting injectables, and IVL-GeneFluidic® for the formulation and manufacturing of Lipid Nanoparticles (LNPs) for nucleic acid and gene therapies. The company's pipeline is focused on treating chronic and refractory diseases, with key programs targeting androgenic alopecia (male pattern baldness) and Alzheimer's disease. Other development areas include drug re-discovery for conditions like rheumatic arthritis and multiple sclerosis, and collaborative projects for HIV treatments and mRNA-based therapies.

Recent filings

Filing Released Lang Actions
[기재정정]전환청구권행사 (제1회차)
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory filing regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the conversion of debt into equity, which affects the company's capital structure and share count. This type of filing is categorized as a capital change or share issue announcement, fitting the 'SHA' (Share Issue/Capital Change) category.
2026-02-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to disclose changes in their shareholdings. This corresponds to the 'Director's Dealing' category, which covers personal share transactions by company directors and executives.
2026-02-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (disposal of shares) by an executive (Ryu Choongho) of Inventage Lab. This type of filing is a standard regulatory requirement for insider trading/director dealings in South Korea, which corresponds to the 'Director's Dealing' category.
2026-02-04 Korean
전환청구권행사 (제1회차)
Share Issue/Capital Change Classification · 95% confidence The document is a formal regulatory filing from Inventage Lab regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares to be issued, the conversion price, and the impact on total shares outstanding. This type of corporate action, involving the conversion of debt into equity, falls under capital structure changes and is classified as a share issue/capital change announcement.
2026-01-23 Korean
주요사항보고서(자기전환사채매도결정)
Regulatory Filings Classification · 95% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding the decision to sell treasury convertible bonds (자기전환사채 매도결정). This type of regulatory filing details specific corporate financial transactions, such as the sale of debt instruments, and falls under the category of general regulatory announcements for corporate events that do not fit into specific categories like dividends or M&A, thus it is classified as a Regulatory Filing (RNS).
2026-01-22 Korean
전환청구권행사 (제3회차)
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (전환사채). It details the number of shares to be issued, the conversion price, and the remaining balance of the convertible bonds. This type of filing relates to changes in capital structure and share issuance resulting from debt conversion, which falls under the 'Share Issue/Capital Change' category.
2026-01-15 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.